Close Menu

CHICAGO (GenomeWeb) – Researchers at the University of California, San Francisco, will use NantHealth's GPS Cancer molecular analysis test to support a new research study on metastatic breast cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.